NCT02838108View on ClinicalTrials.gov

The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort

TerminatedOBSERVATIONAL

Enrollment

452

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 19, 2018

Study Completion Date

April 19, 2018

Conditions

Chronic Obstructive Pulmonary Disease (COPD)EmphysemaChronic Bronchitis

Trial Locations (1)

28081

MURDOCK Study Office, Kannapolis

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Duke University

OTHER